VIRGINIA
BELLIDO CASTAÑEDA
Investigador/a en el periodo 2015-2021
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Virgen del Rocío (9)
2022
-
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications
Diabetes Therapy, Vol. 13, Núm. 5, pp. 873-888
-
Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia
Journal of Clinical Medicine, Vol. 11, Núm. 4
-
Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study
Drugs in Context, Vol. 11
-
Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice
Journal of Diabetes Research, Vol. 2022
-
Once-Weekly Semaglutide Use in Patients with Type 2 Diabetes: Results from the SURE Spain Multicentre, Prospective, Observational Study
Journal of Clinical Medicine, Vol. 11, Núm. 17
2021
-
Covid-19 and diabetes
Journal of Clinical Medicine, Vol. 10, Núm. 22
-
DAPA-RWE: A retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain
Journal of Comparative Effectiveness Research, Vol. 10, Núm. 10, pp. 815-821
-
The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond
Diabetes Therapy, Vol. 12, Núm. 9, pp. 2311-2327
-
Time-in-range for monitoring glucose control: Is it time for a change?
Diabetes Research and Clinical Practice, Vol. 177